Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment
Avita Medical announces that ReCell has demonstrated a very high success rate in the treatment of chronic leg ulcers.
feature2
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
STR, Inc. Advances its ACL Treatment Technology after Receiving $750K in Funding from Connecticut Innovations
The product, L-C Ligament, is considered a breakthrough in the treatment of ACL tears.
Cytomedix Allows Global Pharma Company Exclusivity to Chronic Wound Healing Technology
Cytomedix announced the implementation of a letter agreement allowing an undisclosed global pharmaceutical company an exclusivity period.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Neovasc Aims For CE Mark in 2012
OneMedRadio interviewed Alexei Marko, CEO and Director of Neovasc [CVE:NVC] where he discussed the company’s products for treating heart disease. The company’s flagship product The Reducer is in late stage development.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Technology Brings Virtual Care to Life
Imagine visiting a newborn in another state without having to leave home. Whether enjoying happy moments or navigating serious health issues, there’s a transformation now in how healthcare professionals collaborate in real time.
STENTYS May Solve One of The Biggest Problems In Acute Coronary Syndrome
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
Teribone Treats Osteoporosis With Noninvasive Systematic Approach
It was announced this week that Zosano Pharma, Inc. (Zosano) and Asahei Kasei Pharma (AKP) formed a collaboration to develop Teribone (teriparatide acetate), a transdermal patch treatment for osteoporosis.